- Home
- NNNN vs PSNL Comparison
NNNN vs PSNL Comparison
Compare NNNN & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNNN
- PSNL
- Stock Information
- Founded
- NNNN 2021
- PSNL 2011
- Country
- NNNN Germany
- PSNL United States
- Employees
- NNNN N/A
- PSNL N/A
- Industry
- NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- PSNL Medical Specialities
- Sector
- NNNN Health Care
- PSNL Health Care
- Exchange
- NNNN Nasdaq
- PSNL Nasdaq
- Market Cap
- NNNN 369.6M
- PSNL 426.6M
- IPO Year
- NNNN 2025
- PSNL 2019
- Fundamental
- Price
- NNNN $16.10
- PSNL $6.42
- Analyst Decision
- NNNN
- PSNL Strong Buy
- Analyst Count
- NNNN 0
- PSNL 5
- Target Price
- NNNN N/A
- PSNL $8.00
- AVG Volume (30 Days)
- NNNN 78.0K
- PSNL 922.2K
- Earning Date
- NNNN 01-01-0001
- PSNL 08-06-2025
- Dividend Yield
- NNNN N/A
- PSNL N/A
- EPS Growth
- NNNN N/A
- PSNL N/A
- EPS
- NNNN 0.06
- PSNL N/A
- Revenue
- NNNN $8,185,146.00
- PSNL $85,694,000.00
- Revenue This Year
- NNNN N/A
- PSNL $0.45
- Revenue Next Year
- NNNN N/A
- PSNL $25.75
- P/E Ratio
- NNNN $286.95
- PSNL N/A
- Revenue Growth
- NNNN 21.95
- PSNL 15.57
- 52 Week Low
- NNNN $5.18
- PSNL $1.14
- 52 Week High
- NNNN $18.50
- PSNL $7.20
- Technical
- Relative Strength Index (RSI)
- NNNN N/A
- PSNL 72.69
- Support Level
- NNNN N/A
- PSNL $6.06
- Resistance Level
- NNNN N/A
- PSNL $6.72
- Average True Range (ATR)
- NNNN 0.00
- PSNL 0.44
- MACD
- NNNN 0.00
- PSNL 0.10
- Stochastic Oscillator
- NNNN 0.00
- PSNL 85.65
About NNNN Anbio Biotechnology Class A Ordinary Shares
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.